HK1033338A1 - Use of bacteria endowed with arginine deiminase toinduce apoptosis and/or reduce an inflammatory re action and pharmaceutical or dietetic compositionscontaining such bacteria. - Google Patents

Use of bacteria endowed with arginine deiminase toinduce apoptosis and/or reduce an inflammatory re action and pharmaceutical or dietetic compositionscontaining such bacteria.

Info

Publication number
HK1033338A1
HK1033338A1 HK01104084A HK01104084A HK1033338A1 HK 1033338 A1 HK1033338 A1 HK 1033338A1 HK 01104084 A HK01104084 A HK 01104084A HK 01104084 A HK01104084 A HK 01104084A HK 1033338 A1 HK1033338 A1 HK 1033338A1
Authority
HK
Hong Kong
Prior art keywords
bacteria
toinduce
compositionscontaining
dietetic
apoptosis
Prior art date
Application number
HK01104084A
Other languages
English (en)
Inventor
Claudio De Simone
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Publication of HK1033338A1 publication Critical patent/HK1033338A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01104084A 1998-02-20 2001-06-14 Use of bacteria endowed with arginine deiminase toinduce apoptosis and/or reduce an inflammatory re action and pharmaceutical or dietetic compositionscontaining such bacteria. HK1033338A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000103A IT1298918B1 (it) 1998-02-20 1998-02-20 Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
PCT/IT1998/000275 WO1999042568A1 (en) 1998-02-20 1998-10-13 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria

Publications (1)

Publication Number Publication Date
HK1033338A1 true HK1033338A1 (en) 2001-08-24

Family

ID=11405583

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104084A HK1033338A1 (en) 1998-02-20 2001-06-14 Use of bacteria endowed with arginine deiminase toinduce apoptosis and/or reduce an inflammatory re action and pharmaceutical or dietetic compositionscontaining such bacteria.

Country Status (25)

Country Link
US (2) US6572854B1 (xx)
EP (1) EP1058725B1 (xx)
JP (1) JP4253439B2 (xx)
KR (1) KR100594569B1 (xx)
CN (1) CN1189560C (xx)
AR (2) AR020053A1 (xx)
AT (1) ATE391774T1 (xx)
AU (1) AU754483B2 (xx)
BR (1) BR9815677A (xx)
CA (1) CA2321263C (xx)
CY (1) CY1108112T1 (xx)
DE (1) DE69839351T2 (xx)
DK (1) DK1058725T3 (xx)
EA (1) EA006018B1 (xx)
ES (1) ES2303357T3 (xx)
HK (1) HK1033338A1 (xx)
IL (1) IL137799A (xx)
IN (2) IN188450B (xx)
IT (1) IT1298918B1 (xx)
MX (1) MX237377B (xx)
PT (1) PT1058725E (xx)
SI (1) SI1058725T1 (xx)
TR (1) TR200002326T2 (xx)
WO (1) WO1999042568A1 (xx)
ZA (1) ZA9811619B (xx)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
AUPQ415899A0 (en) * 1999-11-19 1999-12-16 Vasse Research Institute Pty Ltd Compositions for and methods of treatment of allergic diseases
HU227086B1 (en) * 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
FR2809312B1 (fr) * 2000-05-25 2002-07-12 Gervais Danone Sa Utilisation de l. casei dans des compositions immunostimulantes
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
MXPA04001999A (es) * 2001-09-05 2004-07-16 Vsl Pharmaceuticals Inc Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
CN1809378B (zh) * 2002-11-18 2010-06-23 德西涅Rx制药公司 体内抑制病毒复制的方法
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
TW200700074A (en) * 2005-03-04 2007-01-01 Calpis Co Ltd Inducer of t cell apoptosis
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
EA016734B1 (ru) 2006-12-21 2012-07-30 Калпис Ко., Лтд. СРЕДСТВА ДЛЯ СТИМУЛЯЦИИ ПРОДУЦИРОВАНИЯ IgA НА ОСНОВЕ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS И ШТАММ БАКТЕРИЙ LACTOBACILLUS AMYLOVORUS CP1750 FERM BP-10532
CN100584940C (zh) * 2007-05-17 2010-01-27 江南大学 一株产精氨酸脱亚氨酶的菌种及其应用
JP5247120B2 (ja) * 2007-11-02 2013-07-24 雪印メグミルク株式会社 Ｌ−オルニチン含有物の製造方法
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
JP5526320B2 (ja) * 2008-09-04 2014-06-18 国立大学法人旭川医科大学 腸管保護剤
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
ES2575246T3 (es) 2009-10-22 2016-06-27 Kabushiki Kaisha Yakult Honsha Lactobacillus casei para uso en la reducción del riesgo de desarrollar cáncer
EP2559437B1 (en) * 2010-04-08 2016-05-04 National University Corporation Asahikawa Medical University Intestinal protectant
KR101062779B1 (ko) 2010-04-28 2011-09-06 삼육대학교산학협력단 충치 유발 세균의 성장 억제 활성을 나타내는 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 또는 이의 배양물을 유효 성분으로 하는 충치 예방용 식품 및 약제학 조성물
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN102433290B (zh) * 2012-01-16 2013-06-12 江南大学 一株产瓜氨酸的菌株及用该菌株生物合成瓜氨酸的方法
US9731028B2 (en) 2012-04-04 2017-08-15 Polaris Group Methods of treatment with arginine deiminase
EP2968482B1 (en) 2013-03-15 2020-05-06 TDW Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
SG11201605881YA (en) * 2014-01-22 2016-09-29 Meiji Co Ltd Method for preparing citrulline
SG11201607736UA (en) 2014-03-18 2016-10-28 Tdw Group Engineered chimeric pegylated adi and methods of use
TWI775160B (zh) 2014-09-16 2022-08-21 開曼群島商瑞華藥業集團 用於治療癌症之與adi-peg 20抗體具有降低之交叉反應性的精胺酸脫亞胺酶
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
KR102523805B1 (ko) 2014-12-23 2023-04-20 4디 파마 리서치 리미티드 면역 조정
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MX2017016398A (es) 2015-06-15 2018-03-02 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas.
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3240554T (lt) 2015-06-15 2019-11-11 4D Pharma Res Ltd Blautia stercosis ir wexlerae, skirtos naudoti uždegiminių ir autoimuninių ligų gydymui
KR20180012849A (ko) 2015-06-15 2018-02-06 4디 파마 리서치 리미티드 박테리아 균주를 함유한 조성물
EP3209310B1 (en) 2015-11-20 2018-01-31 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN106994134B (zh) * 2016-01-25 2020-08-25 深圳华大生命科学研究院 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MD3313423T2 (ro) 2016-03-04 2019-10-31 4D Pharma Plc Compoziții care conțin tulpini bacteriene de Blautia pentru tratamentul hipersensibilității viscerale
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018125735A1 (en) * 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
CN108265068B (zh) * 2016-12-31 2021-06-15 江苏众红生物工程创药研究院有限公司 重组精氨酸脱亚胺酶及其产业化制备方法和应用
WO2018215758A1 (en) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strains
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SI3638271T1 (sl) 2017-06-14 2021-01-29 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
IL292373A (en) 2017-06-14 2022-06-01 4D Pharma Res Ltd Preparations containing bacterial strains of the Megasphere genus and their use
LT3600363T (lt) 2017-06-14 2021-02-10 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
FR3082207B1 (fr) * 2018-06-06 2022-03-25 Agronomique Inst Nat Rech Nouvelle souche probiotique de lactobacillus brevis
KR102069622B1 (ko) * 2019-06-25 2020-01-23 한국식품연구원 락토바실러스 퍼멘텀 WiKim0102를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
EP4212165A4 (en) * 2020-06-22 2024-07-31 Meiji Co Ltd COMPOSITION TO PROMOTE THE PRODUCTION OF INTERLEUKIN-10
KR102363111B1 (ko) * 2021-06-29 2022-02-15 (주)바이오일레븐 항염 및 항산화 활성을 갖는 락토바실러스 퍼멘텀 균주 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415550A (en) * 1983-03-04 1983-11-15 Pakhomov Gennady N Treatment-and-prophylactic tooth paste possessing anticarious effect
JP2900279B2 (ja) * 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
US5196195A (en) * 1990-03-27 1993-03-23 Cornell Research Foundation, Inc. Use of arginase to control nitric oxide formation
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders
US5599795A (en) * 1994-08-19 1997-02-04 Mccann; Michael Method for treatment of idiopathic inflammatory bowel disease (IIBD)

Also Published As

Publication number Publication date
DK1058725T3 (da) 2008-08-18
CA2321263A1 (en) 1999-08-26
EP1058725A1 (en) 2000-12-13
IL137799A0 (en) 2001-10-31
ES2303357T3 (es) 2008-08-01
AR020053A1 (es) 2002-04-10
ATE391774T1 (de) 2008-04-15
DE69839351T2 (de) 2009-06-25
MXPA00007990A (es) 2001-03-01
SI1058725T1 (sl) 2008-08-31
US6572854B1 (en) 2003-06-03
BR9815677A (pt) 2000-10-24
IN1999KO00116A (xx) 2005-03-11
WO1999042568A1 (en) 1999-08-26
DE69839351D1 (de) 2008-05-21
US20030215429A1 (en) 2003-11-20
AU754483B2 (en) 2002-11-14
AU9644198A (en) 1999-09-06
JP4253439B2 (ja) 2009-04-15
EP1058725B1 (en) 2008-04-09
CA2321263C (en) 2009-08-11
ZA9811619B (en) 1999-06-23
EA006018B1 (ru) 2005-08-25
IL137799A (en) 2005-08-31
KR100594569B1 (ko) 2006-06-30
AR071841A2 (es) 2010-07-21
ITRM980103A1 (it) 1999-08-20
CN1284994A (zh) 2001-02-21
MX237377B (es) 2006-05-31
US7147847B2 (en) 2006-12-12
PT1058725E (pt) 2008-06-19
TR200002326T2 (tr) 2000-11-21
CN1189560C (zh) 2005-02-16
IT1298918B1 (it) 2000-02-07
CY1108112T1 (el) 2014-02-12
IN188450B (xx) 2002-09-28
EA200000856A1 (ru) 2001-02-26
ITRM980103A0 (it) 1998-02-20
KR20010106092A (ko) 2001-11-29
JP2002504324A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
HK1033338A1 (en) Use of bacteria endowed with arginine deiminase toinduce apoptosis and/or reduce an inflammatory re action and pharmaceutical or dietetic compositionscontaining such bacteria.
AU8692198A (en) Amplification using amplitude reconstruction of amplitude and/or angle modulatedcarrier
MXPA01000174A (es) Materiales y metodos para la alteracion de los niveles de enzimas y de acetil-coa en plantas.
NO990296D0 (no) HPPD-genet og inhibitorer
HK1028564A1 (en) Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants.
AU3469199A (en) Maize histone deacetylases and their use
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
DK0763978T3 (da) Forbedringer i og i forbindelse med fremstillingen af næringsmiddelprodukter
AU7813994A (en) Assembly system of shelf stands for dishes and the like
EP0969014A4 (en) BETA-KETOACYL-ACP-SYNTHELASE II ENZYME AND GENE CODING FOR IT
EP0947581A4 (en) CULTURAL MEDIUM AND ITS USE.
IL147534A0 (en) The il-il1 gene and polypeptide products
AU5267800A (en) Polynucleotide probes for detection and quantitation of bacteria in the family enterobacteriaceae
AU5277199A (en) Supergravitational field vortex reactor and the use thereof
GB9807586D0 (en) Enzymes and their use
AU2001268401A1 (en) Body activity detection and processing
GB9623539D0 (en) Enzymes and their use
AU5260598A (en) Detection of mutations in the human atm gene
AU1685201A (en) Drug inducible system and use thereof
EP1072676A4 (en) MICROBIAL CULTURE WITH IMPROVED GLUTAMINASE ACTIVITY AND USE THEREOF
NO20021498D0 (no) PRV-1-genet og anvendelsen av dette
HUP0104954A3 (en) Prv-1 gene and the use thereof
DE60035999D1 (de) Signalprozessor und produkt-summier- vorrichtung mit rundungsfunktion
GB2343613B (en) Shelving systems and shelving assemblies
BR7601412U (pt) Aparelho aplicável no tratamento de fluxo de graos em geral

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: ACTIAL FARMACEUTICA LDA

Free format text: FORMER OWNER(S): MENDES S.R.L. ? ?????????

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171013